Idexx Laboratories Inc (IDXX)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
$2.03 (-0.44%)Past Day

About

Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.

Key Insights

  • Share Price

    $454.52

  • Market Cap

    $37.41 Billion

  • Total Outstanding Shares

    82.31 Million Shares

  • Total Employees

    11,000

  • Dividend

    No dividend

  • IPO Date

    June 21, 1991

  • SIC Description

    In Vitro & In Vivo Diagnostic Substances

  • Homepage

    https://www.idexx.com

Historical Stock Splits

If you bought 1 share of IDXX before November 27, 2007, you'd have 4 shares today.
Execution DateSplit Amount
June 16, 20152-for-1
November 27, 20072-for-1

Cash Flow Statement

July 1, 2023 to June 30, 2024
MetricValue
Net Cash Flow$268.75 Million
Net Cash Flow From Investing Activities$-198.12 Million
Net Cash Flow From Investing Activities, Continuing$-198.12 Million
Net Cash Flow From Operating Activities, Continuing$969.18 Million
Net Cash Flow From Operating Activities$969.18 Million
Net Cash Flow From Financing Activities$-499.19 Million
Net Cash Flow, Continuing$271.86 Million
Net Cash Flow From Financing Activities, Continuing$-499.19 Million
Exchange Gains/Losses$-3.11 Million

Income Statement

July 1, 2023 to June 30, 2024
MetricValue
Cost Of Revenue$1.50 Billion
Preferred Stock Dividends And Other Adjustments$0.00
Basic Average Shares$165.97 Million
Gross Profit$2.29 Billion
Diluted Average Shares$167.66 Million
Net Income/Loss Attributable To Parent$845.63 Million
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic$0.00
Income/Loss From Continuing Operations After Tax$845.63 Million
Income Tax Expense/Benefit, Deferred$-57.40 Million
Net Income/Loss Available To Common Stockholders, Basic$845.63 Million
Net Income/Loss Attributable To Noncontrolling Interest$0.00
Revenues$3.78 Billion
Diluted Earnings Per Share$10.08
Income/Loss From Continuing Operations Before Tax$1.06 Billion
Research and Development$207.86 Million
Benefits Costs and Expenses$2.72 Billion
Net Income/Loss$845.63 Million
Operating Expenses$1.20 Billion
Income Tax Expense/Benefit$216.47 Million
Operating Income/Loss$1.08 Billion
Provision For Loan, Lease, And Other Losses$5.44 Million
Basic Earnings Per Share$10.19
Other Operating Expenses$995.17 Million
Costs And Expenses$2.72 Billion

Balance Sheet

July 1, 2023 to June 30, 2024
MetricValue
Other Non-current Assets$1.07 Billion
Prepaid Expenses$46.45 Million
Liabilities$1.83 Billion
Noncurrent Liabilities$717.91 Million
Equity Attributable To Noncontrolling Interest$0.00
Inventory$379.96 Million
Noncurrent Assets$1.89 Billion
Liabilities And Equity$3.41 Billion
Current Assets$1.53 Billion
Accounts Payable$117.47 Million
Wages$124.02 Million
Current Liabilities$1.12 Billion
Intangible Assets$110.81 Million
Equity Attributable To Parent$1.58 Billion
Other Current Assets$1.10 Billion
Other Current Liabilities$875.22 Million
Fixed Assets$708.18 Million
Equity$1.58 Billion
Assets$3.41 Billion

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
News ArticlesAbout UsPrivacy Policy & Cookies Information

ⓒ2024 Financhle. All Rights Reserved.